Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fluid Biomed
Calgary, Alberta, Canadafluidbiomed.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
The company has developed ReSolv™, the world’s first hybrid polymer-metal flow-diverting stent for treating brain aneurysms. Initial first-in-human clinical safety trials have begun internationally with successful device implantation and no adverse effects at the early time points. The technology aims to improve patient outcomes by providing a bioabsorbable scaffold that promotes blood vessel healing and reduces the need for lifelong blood thinners or invasive follow-up procedures. Expanded human studies are planned following recent Series A funding.
- Therapeutic areas
- Neurology
- Modalities
- Devicepolymer-metal hybrid stent (bioabsorbable polymer-based stent)
- Industry
- Therapeutic Medical Devices
02
Partnerships
University of Calgary/Innovate Calgary/UCeed Health Fund (academic/commercialization support)Amplitude Ventures, IAG Capital Partners, LifeArc Ventures, ShangBay Capital, METIS Innovative (investors/strategic partners)
Beyond the preview
Go deeper on Fluid Biomed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fluid Biomed.